| | | | | | | | | MLO wishes you and your families a happy holiday! There will not be LABline editions on Wednesday or Thursday, but newsletters will resume on Friday featuring highlights from 2025. |
|
|
|
| |
| | |
|
|
| | | | | | A recent Northwestern Medicine and University of Michigan study has validated a new blood test that reveals whether chemotherapy for glioblastoma is working or not, leading to timely treatment and better patient outcomes, according to an announcement. |
|
|
| | Learn to list the epidemiological and healthcare statistics for TB infections, discuss transmission mode and the current disease states of TB, discuss the various TB laboratory methodologies and their limitations, and list new innovations in the evolution of TB testing with our December CE! |
|
|
|
| |
| | |
|
|
| | | | | | Roche's Lunsumio VELO, a bispecific antibody, gained FDA approval for subcutaneous use treating adult relapsed or refractory follicular lymphoma after multiple therapies, based on positive phase I/II trial results showing high response rates and manageable safety profile. |
|
|
|
| |
| | |
|
|
| | | | | | The MLO editors are seeking industry input on Laboratory Data Analytics through a brief survey, open until December 31, 2025. Your participation will help shape the future of the field and inform the upcoming report. |
|
|
|
| |
| | |
|
|
| | | | Sponsored | | Thrombocytopenia remains a diagnostic challenge, with causes that range from benign conditions to life-threatening disorders. This guide explores how modern hematology tools empower laboratories to lead in early detection and classification of thrombocytopenia. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|
